Cibc World Markets Corp Eli Lilly & CO Transaction History

Cibc World Markets Corp

$15 Billion
Q1 2024

A detailed history of Cibc World Markets Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Cibc World Markets Corp holds 119,327 shares of LLY stock, worth $108 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

119,327

Previous 102,906 15.96%

Holding current value

$108 Million

Previous $60 Million 54.76%

% of portfolio

0.62%

Previous 0.33%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $9.72 Million - $13 Million	16,421 Added 15.96%	119,327 $92.8 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $30.9 Million - $36.5 Million	58,894 Added 133.81%	102,906 $60 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $21 Million - $29 Million	-48,326 Reduced 52.34%	44,012 $23.6 Million
Q2 2023 Aug 04, 2023	BUY	$350.74 - $468.98 $18.4 Million - $24.6 Million	52,457 Added 131.53%	92,338 $43.3 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $63 Million - $74 Million	-202,837 Reduced 83.57%	39,881 $13.7 Million

Q4 2022 Feb 09, 2023	BUY	$321.55 - $374.67 $74.2 Million - $86.5 Million	230,751 Added 1928.23%	242,718 $88.8 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $12.8 Million - $14.6 Million	-43,087 Reduced 78.26%	11,967 $3.87 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $30.2 Million - $35.4 Million	-108,286 Reduced 66.29%	55,054 $17.9 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $3.19 Million - $3.97 Million	13,601 Added 9.08%	163,340 $46.8 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $6.61 Million - $8.21 Million	-29,412 Reduced 16.42%	149,739 $41.4 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $21.9 Million - $26.9 Million	98,737 Added 122.79%	179,151 $41.4 Million
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $960,887 - $1.24 Million	-5,322 Reduced 6.21%	80,414 $18.5 Million
Q1 2021 May 07, 2021	SELL	$164.32 - $212.72 $9.95 Million - $12.9 Million	-60,560 Reduced 41.4%	85,736 $16 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $4.06 Million - $5.37 Million	-31,117 Reduced 17.54%	146,296 $24.7 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $13.8 Million - $16 Million	94,719 Added 114.54%	177,413 $26.3 Million
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $2.85 Million - $3.42 Million	20,857 Added 33.73%	82,694 $13.6 Million
Q1 2020 May 12, 2020	SELL	$119.05 - $147.35 $32 Million - $39.6 Million	-268,672 Reduced 81.29%	61,837 $8.58 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $2.12 Million - $2.62 Million	-19,809 Reduced 5.65%	330,509 $43.4 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $15.9 Million - $17.3 Million	148,767 Added 73.81%	350,318 $39.2 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $18.1 Million - $21.1 Million	-163,125 Reduced 44.73%	201,551 $22.3 Million
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $6.56 Million - $7.72 Million	58,901 Added 19.26%	364,676 $47.3 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $4.39 Million - $4.92 Million	41,475 Added 15.69%	305,775 $35.4 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $4.47 Million - $5.58 Million	52,022 Added 24.51%	264,300 $28.4 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $2.54 Million - $2.92 Million	33,560 Added 18.78%	212,278 $18.1 Million
Q1 2018 May 11, 2018	SELL	$74.21 - $87.6 $15.8 Million - $18.6 Million	-212,889 Reduced 54.36%	178,718 $13.8 Million
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $18.4 Million - $19.7 Million	224,198 Added 133.92%	391,607 $33.1 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $12.9 Million - $14.3 Million	167,409	167,409 $14.3 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.

Account

Cibc World Markets Corp Eli Lilly & CO Transaction History